Acute gastrointestinal bleeding among patients on antiplatelet and anticoagulant therapy after percutaneous coronary intervention.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Sveinsdottir, AsdisGudmundsdottir, Ingibjörg J
Hreinsson, Johann P
Andersen, Karl
Björnsson, Einar S
Issue Date
2021-04-01
Metadata
Show full item recordCitation
Sveinsdottir A, Gudmundsdottir IJ, Hreinsson JP, Andersen K, Björnsson ES. Acute gastrointestinal bleeding among patients on antiplatelet and anticoagulant therapy after percutaneous coronary intervention. Scand J Gastroenterol. 2021 Apr 1:1-7. doi: 10.1080/00365521.2021.1906945. Epub ahead of print. PMID: 33794728.Abstract
Background: Patients undergoing percutaneous coronary intervention (PCI) require dual antiplatelet therapy and some require additional anticoagulation. We aimed to investigate the incidence of acute gastrointestinal bleeding (AGIB) among PCI patients receiving antiplatelet and anticoagulant therapy. Methods: A population-based study that included all patients undergoing PCI during 2008-2016 in Iceland. Data from the Icelandic Medicines Registry were obtained on all outpatient prescriptions 1 year after first PCI. Patients receiving single or dual-antiplatelet therapy with or without anticoagulation cotherapy were analyzed. Rehospitalization for AGIB and endoscopic data were obtained within the 12-month follow-up period. Results: A total of 5166 patients (male 75%) underwent PCI during the study period. The incidence of AGIB was 1% (54/5166) per year. The mean age among non-bleeders 65 (±11) years was lower than among bleeders 69 (±9) years (p = .002). The proportion of acute upper GIB (AUGIB) was 56%, whereas lower GIB occurred in 44%. Overall, 41% with AUGIB had PPIs compared to 39% of non-bleeders (NS). The incidence of AGIB among patients on single antiplatelet therapy combined with an anticoagulant was 2.5% compared to 0.9% among those on single antiplatelet treatment alone (p = .028). The number needed to harm (NNH) for treatment with single antiplatelet therapy and anticoagulant therapy compared to single antiplatelet therapy was 62 but no deaths related to AGIB. Conclusions: The 1-year incidence of AGIB was low with no mortality. Bleeding risk was found to be higher among patients on single antiplatelet therapy combined with anticoagulant therapy compared to patients on single antiplatelet therapy alone. Keywords: Acute gastrointestinal bleeding; anticoagulant therapy; antiplatelet therapy; dual antiplatelet therapy; incidence; number needed to harm; percutaneous coronary intervention.Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://www.tandfonline.com/doi/full/10.1080/00365521.2021.1906945ae974a485f413a2113503eed53cd6c53
10.1080/00365521.2021.1906945
Scopus Count
Collections
Related articles
- Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
- Authors: Patel NJ, Pau D, Nalluri N, Bhatt P, Thakkar B, Kanotra R, Agnihotri K, Ainani N, Patel N, Patel N, Shah S, Kadavath S, Arora S, Sheikh A, Badheka AO, Lafferty J, Alfonso C, Cohen M
- Issue date: 2016 Oct 15
- [The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
- Authors: Zhang ZF, Sha WH, Tan GY, Wang QY
- Issue date: 2016 Jun
- Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
- Authors: Koskinas KC, Räber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blöchlinger S, Moro C, Jüni P, Meier B, Heg D, Windecker S
- Issue date: 2015 May
- Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary intervention.
- Authors: Zhu P, Tang X, Xu J, Song Y, Liu R, Zhang Y, Gao L, Gao Z, Chen J, Yang Y, Gao R, Xu B, Yuan J
- Issue date: 2018 Oct
- Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age.
- Authors: Abraham NS, Noseworthy PA, Inselman J, Herrin J, Yao X, Sangaralingham LR, Cornish G, Ngufor C, Shah ND
- Issue date: 2020 Feb